Reviewed 5 authoritative sources spanning antibody structure/function (Wikipedia), cancer immunotherapy research articles (PMC), antibody therapeutic registries (Antibody Society), and technical guides (Abcam)
Cross-referenced entries in clinical trial databases, therapeutic antibody tables, and research publications
Applied multiple search filters: antibody nomenclature databases, gene/protein aliases, and sequence-based identifiers
Scenario 1 - Nomenclature Error
May represent a typographical error (e.g., CXCL1 vs CAX1c)
Could involve confusion with established antibodies:
Scenario 2 - Undisclosed Research
Potential early-stage development not yet published
May exist under proprietary codes in corporate pipelines
Scenario 3 - Hypothetical Construct
Could reference unpublished computational models
Might involve non-standard naming conventions
Nomenclature Verification
Confirm spelling through:
Alternative Search Strategies
Sequence-based queries if structural data exists
Patent database searches (USPTO, WIPO)
Conference abstracts from recent immunology meetings
CAX1c Antibody is primarily used in several key experimental applications: (1) Western blotting to detect and quantify CAX1c protein expression levels in different tissues or under various treatment conditions; (2) Immunoprecipitation to isolate CAX1c and its interacting partners; (3) Immunohistochemistry and immunofluorescence to visualize the subcellular localization of CAX1c; (4) ELISA-based assays to quantitatively measure CAX1c levels in plant extracts; and (5) Chromatin immunoprecipitation (ChIP) when studying transcription factors that may regulate CAX1c expression. These applications allow researchers to investigate CAX1c's role in calcium homeostasis, stress responses, and developmental processes in rice and potentially other plant species.
For effective CAX1c detection, sample preparation must preserve the native protein structure while ensuring sufficient extraction efficiency. Begin by flash-freezing freshly harvested rice tissues in liquid nitrogen before grinding to a fine powder. For membrane protein extraction (as CAX1c is membrane-localized), use a buffer containing 50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1% Triton X-100 or 0.5% sodium deoxycholate, 1 mM EDTA, and protease inhibitor cocktail. Maintain samples at 4°C throughout processing to prevent degradation. For particularly recalcitrant samples, consider using specialized plant protein extraction kits that account for the high levels of phenolic compounds and polysaccharides in plant tissues. Following extraction, centrifuge at 14,000 × g for 15 minutes and collect the supernatant. Measure protein concentration using Bradford or BCA assays, adjusting final concentrations to 1-5 μg/μL depending on your specific application. This methodical approach ensures consistent results across different experimental conditions and biological replicates.
For optimal Western blot detection of CAX1c, careful attention to several parameters is essential. Load 20-50 μg of total protein per lane on a 10-12% SDS-PAGE gel to ensure adequate separation of membrane proteins. Following transfer to a PVDF membrane (preferred over nitrocellulose for membrane proteins), block with 5% non-fat dry milk or BSA in TBST for 1 hour at room temperature. Incubate with CAX1c Antibody at a 1:500 to 1:1000 dilution overnight at 4°C, followed by 3-5 thorough washes with TBST. For detection, use a secondary antibody conjugated to HRP at 1:5000 dilution for 1 hour at room temperature. To enhance signal-to-noise ratio, consider using longer blocking times (up to 2 hours) and extended washing steps after both primary and secondary antibody incubations. For membrane proteins like CAX1c, inclusion of 0.1% SDS in the blocking buffer may reduce background. Always run appropriate positive controls and size markers to confirm the expected molecular weight of approximately 50 kDa for CAX1c.
When conducting immunofluorescence studies with CAX1c Antibody, implementing rigorous controls is critical for data validation. Essential controls include: (1) Primary antibody omission control - process samples with secondary antibody only to assess non-specific binding; (2) Secondary antibody specificity control - use isotype-matched irrelevant primary antibody to evaluate secondary antibody specificity; (3) Absorption control - pre-incubate primary antibody with excess immunizing peptide to confirm specificity; (4) Positive control - include samples known to express CAX1c; (5) Negative control - use CAX1c knockout/knockdown tissues if available. For co-localization studies, include single-labeled controls to account for bleed-through. Additionally, when using fixed tissues, autofluorescence controls (untreated tissue sections) help distinguish true signal from inherent plant fluorescence, particularly important with rice tissues which contain natural fluorescent compounds. Implementing these methodological controls ensures that observed signals genuinely represent CAX1c localization rather than artifacts.
For successful co-immunoprecipitation (Co-IP) studies with CAX1c Antibody, begin with optimized extraction conditions that preserve protein-protein interactions. Use a gentle lysis buffer containing 50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 0.5% NP-40 or 0.1% Digitonin, 5 mM EDTA, 1 mM DTT, and protease/phosphatase inhibitors. Pre-clear the lysate with Protein A/G beads for 1 hour at 4°C to reduce non-specific binding. Incubate 1-5 mg of pre-cleared lysate with 2-5 μg of CAX1c Antibody overnight at 4°C with gentle rotation, followed by addition of 30-50 μL Protein A/G beads for 3-4 hours. After thorough washing with decreasing detergent concentrations (4-5 washes), elute protein complexes with either low pH buffer or SDS sample buffer. For crosslinking studies to capture transient interactions, use membrane-permeable crosslinkers like DSP or formaldehyde. Analyze the immunoprecipitated fractions by immunoblotting or mass spectrometry to identify interaction partners. Always include appropriate controls such as IgG control, input sample, and where available, CAX1c-deficient samples to distinguish specific from non-specific interactions.
To accurately quantify CAX1c protein expression across different conditions, researchers should implement multiple complementary approaches. For Western blot-based quantification, use housekeeping proteins like actin, tubulin, or membrane-specific controls such as H+-ATPase as loading controls, ensuring they remain stable under your experimental conditions. Perform densitometry analysis using software like ImageJ, normalizing CAX1c band intensity to loading controls. For higher throughput and precision, develop an ELISA protocol using CAX1c Antibody as the capture antibody and a different epitope-targeting antibody for detection. qPCR can complement protein data by measuring CAX1c mRNA levels, though post-translational regulation may cause discrepancies between mRNA and protein abundance. For absolute quantification, consider developing a standard curve using recombinant CAX1c protein. When comparing expression across different tissues or treatments, biological replicates (minimum n=3) and appropriate statistical analysis are essential. This multi-method approach provides robust quantification data that accounts for technical variations inherent in each method.
Visualizing changes in CAX1c localization and expression under environmental stress requires a multi-faceted imaging approach. For subcellular localization studies, combine immunofluorescence using CAX1c Antibody with organelle-specific markers for tonoplast, plasma membrane, and endoplasmic reticulum. Use confocal microscopy with z-stack imaging to create 3D reconstructions of CAX1c distribution. For dynamic studies, time-course experiments with samples collected at multiple timepoints after stress application (e.g., 0, 1, 3, 6, 12, 24 hours) reveal temporal patterns of relocalization. Complement immunofluorescence with subcellular fractionation followed by Western blotting to quantitatively assess redistribution between cellular compartments. For whole-tissue distribution patterns, immunohistochemistry on tissue sections provides spatial context. To correlate CAX1c localization with functional calcium homeostasis, combine immunofluorescence with calcium-sensitive fluorescent indicators like Fluo-4 or genetically encoded calcium indicators. This comprehensive visualization strategy enables researchers to connect CAX1c relocalization with cellular calcium dynamics under various stressors such as salt, drought, or pathogen exposure.
While CAX1c itself is not a transcription factor, CAX1c Antibody can be valuable in modified ChIP approaches to study its transcriptional regulation. Researchers can implement chromatin interaction analysis by paired-end tag sequencing (ChIA-PET) or proximity ligation-assisted ChIP-seq (PLAC-seq) to identify long-range chromatin interactions affecting CAX1c expression. For direct transcription factor studies, use standard ChIP protocols with antibodies against suspected transcription factors, focusing on the CAX1c promoter region. Begin by crosslinking proteins to DNA using 1% formaldehyde for 10 minutes, followed by quenching with 125 mM glycine. After cell lysis, sonicate chromatin to generate 200-500 bp fragments. Immunoprecipitate with antibodies against transcription factors predicted to regulate CAX1c, then reverse crosslinks and purify DNA. Analyze enrichment at the CAX1c promoter using qPCR with primers spanning predicted binding sites or through ChIP-seq for genome-wide binding profiles. This approach can reveal how environmental signals regulate CAX1c expression through specific transcription factors, connecting external stimuli to calcium transport regulation.
When adapting CAX1c Antibody protocols across different plant species or tissues, several critical modifications are necessary. First, assess cross-reactivity through sequence alignment of CAX1c homologs in your species of interest with the rice CAX1c epitope recognized by the antibody. For species with significant sequence divergence, higher antibody concentrations (1:200-1:300 for Western blots) may be required, with extended incubation times. For woody tissues or those with high secondary metabolite content, modify extraction buffers by adding 2% PVPP, 5 mM ascorbic acid, and 5 mM DTT to prevent interference from phenolics and oxidation. When working with green tissues, additional centrifugation steps (15,000 × g for 15 minutes) help remove chlorophyll and other pigments that can increase background. For recalcitrant tissues, consider protein extraction methods that use TCA/acetone precipitation followed by phenol extraction. During immunolocalization in tissues with thick cell walls, extend enzymatic digestion times (cellulase/pectinase treatment) and optimize permeabilization conditions. Always validate antibody specificity in each new species through Western blotting before proceeding to more complex applications like immunoprecipitation or immunolocalization.
Integrating CAX1c immunodetection with calcium imaging provides powerful insights into the relationship between CAX1c distribution and functional calcium dynamics. For sequential analysis, perform calcium imaging in living cells using ratiometric dyes like Fura-2 or genetically encoded calcium indicators (GECIs) such as GCaMP variants, followed by fixation and immunodetection of CAX1c. For simultaneous visualization, use spectrally distinct fluorophores - for example, a red fluorophore-conjugated secondary antibody for CAX1c detection combined with green-emitting calcium indicators. In fixed samples, complement CAX1c immunolocalization with histochemical calcium detection using chlortetracycline fluorescence or Fluo-3/AM in permeabilized tissue. For single-cell resolution in intact tissues, consider using tissue clearing techniques like ClearSee combined with CAX1c immunodetection and calcium staining. Data analysis should include colocalization statistics between CAX1c signals and calcium hotspots using Pearson's or Mander's coefficients. This combined approach allows researchers to directly correlate CAX1c expression patterns with altered calcium dynamics under various environmental conditions or developmental stages, providing mechanistic insights into CAX1c function.
CAX1c Antibody offers valuable applications in plant biotechnology initiatives aimed at crop improvement. It can be used to screen transgenic lines overexpressing or silencing CAX1c to confirm protein expression levels before phenotypic evaluation. In biofortification programs targeting increased calcium content in rice grains, the antibody enables monitoring of CAX1c expression across different developmental stages and in response to calcium supplementation. For stress tolerance improvement, CAX1c Antibody facilitates screening of natural variants with altered CAX1c expression or localization that correlate with enhanced drought or salt tolerance. In breeding programs, develop high-throughput ELISA protocols using the antibody to screen large populations for desired CAX1c expression patterns. The antibody can also validate gene editing outcomes when CAX1c is targeted through CRISPR/Cas9 approaches. For translational research, use immunohistochemistry with CAX1c Antibody to compare subcellular distribution between model and crop plants to validate the conservation of calcium transport mechanisms. These biotechnology applications connect basic research on calcium transporters to practical agricultural improvements in nutrient content and stress resilience.
Resolving contradictory findings about CAX1c function requires systematic methodological approaches addressing multiple variables. Begin by establishing standardized extraction and detection protocols across laboratories to eliminate technical variations. Conduct side-by-side comparisons using both in vitro and in vivo systems, as membrane protein function can differ significantly between these contexts. When contradictions occur between species, perform phylogenetic analysis followed by complementation studies where rice CAX1c is expressed in other plant systems to test functional conservation. For discrepancies in protein-protein interactions, use multiple interaction detection methods (Y2H, BiFC, Co-IP, FRET) as each has specific strengths and limitations. Employ CRISPR/Cas9 to generate precise CAX1c knockouts to resolve questions about phenotypes observed in earlier RNAi or antisense studies that may have had off-target effects. For controversies regarding subcellular localization, combine immunolocalization using CAX1c Antibody with fractionation studies and functional transport assays using isolated membrane vesicles. This comprehensive approach addresses methodological limitations inherent in individual techniques and provides a foundation for consensus regarding CAX1c function across different experimental contexts.
Developing quantitative assays that correlate CAX1c protein levels with calcium transport activity requires integrating immunodetection with functional transport measurements. First, establish a quantitative ELISA using CAX1c Antibody to precisely measure protein levels in membrane fractions. Concurrently, isolate matching membrane vesicles for transport assays using 45Ca2+ uptake measurements in the presence of various pH gradients (since CAX1c is a Ca2+/H+ exchanger). Plot 45Ca2+ transport rates against CAX1c protein levels to establish correlation coefficients. For in vivo correlation, combine CAX1c quantification in different tissues or treatments with calcium content analysis using atomic absorption spectroscopy or ICP-MS. Develop a microplate-based fluorometric assay where CAX1c is immunoprecipitated with the antibody and its transport activity measured using calcium-sensitive fluorophores. For spatial correlation, use ratiometric imaging of calcium indicators in specific subcellular compartments combined with quantitative immunofluorescence of CAX1c. This multi-parameter approach allows researchers to develop mathematical models relating CAX1c abundance, distribution, and post-translational modifications to calcium transport capacity under various physiological conditions.